FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical composition of 2,2′-di(pyridin-4-yl)-1H,1′H-5,5′-bibenzo[d]imidazole, as well as to using it in producing a drug for treating C. Difficile-associated diarrhoea (CDAD) by selective bacteriostatic and/or bactericidal activity on Clostridium difficile as compared to C. perfringens, Staphylococcus aureus, Enterococcus faecium, Enterococcus faecalis, Bacillus subtilis and Bacteroides fragilis.
EFFECT: what is prepared is the new pharmaceutical composition possessing effective biological properties.
2 cl, 8 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES | 2011 |
|
RU2575477C2 |
| ANIONIC POLYMERS BEING THE SUBSTANCES FOR BINDING TOXINS AND ANTIBACTERIAL SUBSTANCES | 2000 |
|
RU2246938C2 |
| NOVEL ANTIBACTERIAL MEDICATIONS FOR TREATMENT OF GRAM-POSITIVE INFECTIONS | 2009 |
|
RU2512396C2 |
| 5-HYDROXYMETHYLOXAZOLIN-2-ONE DERIVATIVES FOR TREATING BACTERIAL INTESTINAL DISEASES | 2009 |
|
RU2527769C2 |
| MACROCYCLIC POLYMORPHS, COMPOSITIONS CONTAINING SUCH POLYMORPHS, AND METHODS FOR USING AND PREPARING THEM | 2008 |
|
RU2478643C2 |
| TREATMENT OF BACTERIAL INFECTIONS | 2005 |
|
RU2377251C2 |
| PEPTIDES AND USE THEREOF | 2011 |
|
RU2590706C2 |
| IMMUNOGENIC COMPOSITION FOR TREATMENT OR PREVENTION OF CLOSTRIDIUM DIFFICILE, METHOD OF OBTAINING THEREOF AND METHOD OF INDUCING IMMUNE RESPONSE TO C DIFFICILE | 2008 |
|
RU2550271C2 |
| KIBDELOS PORANGIUM EXTRACTS AS ANTIBACTERIAL AGENTS | 2010 |
|
RU2572621C2 |
| METHODS FOR TREATMENT AND PREVENTION OF C. DIFFICILE INFECTION | 2017 |
|
RU2751509C1 |
